Plain-English translation of NCT04978571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called Percutaneous Electrical Nerve Field Stimulation (PENFS), which uses tiny needles to place small devices on your outer ear that deliver gentle electrical stimulation. Researchers want to see if this treatment can help children and teens who have had ongoing symptoms from a concussion or from long-term COVID-19 that hasn't improved after at least 3 months. Some participants will receive active devices (the real treatment) and some will receive inactive devices (a control) so doctors can fairly compare how well the treatment works.
Many children and teens struggle with lasting symptoms after a concussion or long-term COVID that don't go away with standard care. Researchers are exploring whether this electrical nerve stimulation device might help reduce these persistent symptoms and improve quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll have small electrical stimulation devices placed on your outer ear through tiny needles. You'll wear each device for 5 days straight, 24 hours a day, then remove it on the 6th day—this happens weekly for 4 to 6 weeks depending on which group you're in. You'll also complete several tests including balance checks, heart rhythm tests, eye tests, and questionnaires. The study visits last 8 to 12 weeks total, and you may receive the active treatment right away or after an initial waiting period.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States